Literature DB >> 10729940

A practical approach to the treatment of patients with borderline personality disorder.

W J Livesley1.   

Abstract

This approach to the treatment of BPD is part of a general framework for treating all forms of personality disorder. The therapeutic model has two components: (1) general strategies to manage core self and interpersonal pathology that characterizes all cases of personality disorder and (2) a specific or tailored component required to treat the problems of individual cases. The general strategies, derived from generic models of therapeutic change and self-psychology, emphasize the therapeutic relationship and the importance of a consistent treatment process, validation, and building motivation. A combination of specific interventions, including medication and psychotherapeutic strategies drawn from treatment approaches, is incorporated into this framework as required. The overall model is not an eclectic approach to treatment but an integrated framework based on an understanding of borderline pathology that emerges from recent research.

Entities:  

Mesh:

Year:  2000        PMID: 10729940     DOI: 10.1016/s0193-953x(05)70152-0

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  3 in total

Review 1.  Efficacy and tolerability of pharmacotherapies for borderline personality disorder.

Authors:  Silvio Bellino; Erika Paradiso; Filippo Bogetto
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

2.  Comparison of treatment outcomes in severe personality disorder patients with or without substance use disorders: a 36-month prospective pragmatic follow-up study.

Authors:  Fernando Lana; Carmen Sánchez-Gil; Núria D Adroher; Víctor Pérez; Guillem Feixas; Josep Martí-Bonany; Marta Torrens
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-21       Impact factor: 2.570

3.  Borderline personality disorder: bipolarity, mood stabilizers and atypical antipsychotics in treatment.

Authors:  Hasan Belli; Cenk Ural; Mahir Akbudak
Journal:  J Clin Med Res       Date:  2012-09-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.